MUC5AC and colitis: In addition, the anti-IL23P19 treatment improved many cardinal signs of colitis in the animals, including the area of ulceration, a depletion of mucin-producing goblet and epithelial cells, a thickening of the muscular layer, degree of leukocyte and PMN infiltration, as well as histological scores (Fig. 1b-d).